Capmatinib in METex14-mutated (mut) advanced non-small cell lung cancer (NSCLC): Results from the phase II GEOMETRY mono-1 study, including efficacy in patients (pts) with brain metastases (BM)

Edward B. Garon, Rebecca S. Heist, Takashi Seto, Ji-Youn Han, Noemi Reguart, Harry J. Groen, Daniel S. W. Tan, Toyoaki Hida, Maja J. de Jonge, Sergey Orlov, Egbert F. Smit, Pierre-Jean Souquet, Johan Vansteenkiste, Sylvie Le Mouhaer, Anna Robeva, Maeve Waldron-Lynch, Monica Giovannini, Juergen Wolf

OnderzoeksoutputAcademic

Originele taal-2English
Aantal pagina's3
TijdschriftCancer Research
Volume80
Nummer van het tijdschrift16
DOI's
StatusPublished - aug.-2020
EvenementAACR Annual Meeting -
Duur: 22-jun.-202024-jun.-2020

Citeer dit